Arcturus Therapeutics Holdings Inc. (ARCT) › Shareholders' EquityArcturus Therapeutics Holdings Inc. (ARCT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: $33.79M2018: $13.64M2019: $25.79M2020: $396.55M2021: $228.21M2022: $270.31M2023: $278.51M2024: $240.98M2025: $213.99M$213.99M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$213.99M-11.2%2024$240.98M-13.5%2023$278.51M+3.0%2022$270.31M+18.4%2021$228.21M-42.5%2020$396.55M+1437.5%2019$25.79M+89.1%2018$13.64M-59.6%2017$33.79M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share